Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.
Clinical trial NCT01451775 · COMPLETED
Trial details
- NCT number
- NCT01451775
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2011-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.